Murex Pharmaceuticals Licenses Ariadne’s Pathway Studio Software Solution To Be Utilized For Cancer Therapeutics Development – July 27, 2006
Ariadne Genomics, Inc. today announced that Murex Pharmaceuticals (Dallas, Texas) has licensed its Pathway Studio® software solution for the visualization and analysis of biological pathways and gene regulation networks. Murex will use Pathway Studio to develop computer-based models for the identification and validation of cancer targets..